Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.517NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
B.1.427 (Epsilon)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.429 (Epsilon)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.166NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.86NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.154NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.137NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.446NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.76 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.398NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.163NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22077.4South Korea
P.3 (Theta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.254NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.418NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.122NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAJNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.431NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.168NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.6 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.97NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.59NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.277NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-211.894South Korea
AY.28 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.272NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.371NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.353NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.407NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.182NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.218NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.12.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.22 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used